Judge Rules Unreported Clinical Trial Data Must Be Made Public
Judge Rules Unreported Clinical Trial Data Must Be Made Public
The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.
Judge Rules Unreported Clinical Trial Data Must Be Made Public
Judge Rules Unreported Clinical Trial Data Must Be Made Public

The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.

The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.

transparency
<em>ProPublica</em> Creates Database of Researchers&rsquo; Conflicts of Interest
ProPublica Creates Database of Researchers’ Conflicts of Interest
Jef Akst | Dec 9, 2019
The nonprofit newsroom has collected more than 29,000 disclosures of faculty members’ outside income, but they represent just the tip of the iceberg.
EPA Plans Modifications to Controversial Transparency Proposal
EPA Plans Modifications to Controversial Transparency Proposal
Shawna Williams | Nov 12, 2019
The changes would further restrict which scientific findings can be used in drafting regulations.
Fixing the Flaws in Animal Research
Fixing the Flaws in Animal Research
Diana Kwon | Sep 1, 2019
Many preclinical studies carried out in vivo are poorly designed and generate irreproducible data, but efforts to address the problem are on the rise.
Opinion: Transparency Is Critical to Defend Animal Research
Opinion: Transparency Is Critical to Defend Animal Research
Cindy Buckmaster | Apr 11, 2019
Research organizations should start sharing with the public information, stories, photos, and videos on how animals are cared for and used in science.
Drop Statistical Significance, Scientists Say
Drop Statistical Significance, Scientists Say
Carolyn Wilke | Mar 21, 2019
In service of an arbitrary threshold, p-values often lead researchers to make poorly supported claims and ignore interesting but insignificant results, scientists argue.
Q&amp;A: John Ioannidis Talks Transparency in Biomedical Literature
Q&A: John Ioannidis Talks Transparency in Biomedical Literature
Shawna Williams | Nov 20, 2018
The Stanford University researcher discusses a new study on measures such as data sharing and funding disclosures.
EPA Postpones Decision on Rule to Restrict Scientific Input
EPA Postpones Decision on Rule to Restrict Scientific Input
Jef Akst | Oct 19, 2018
It will be more than a year before the agency institutes or rejects the controversial changes proposed by former EPA head Scott Pruitt.
Studies Unable to Reproduce Results of Two Diabetes Papers
Studies Unable to Reproduce Results of Two Diabetes Papers
Anna Azvolinsky | Aug 10, 2018
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
US Scientists’ Letter Calls for Transparency in Animal Research
US Scientists’ Letter Calls for Transparency in Animal Research
Ashley Yeager | Jun 21, 2018
Nearly 600 signatories, including four Nobel Prize winners, urge openness about animal experiments.
Medical Statistician Doug Altman Dies
Medical Statistician Doug Altman Dies
Kerry Grens | Jun 5, 2018
The cofounder of the EQUATOR Network devoted his career to boosting transparency and improving the quality of clinical research.
EPA Seeks to Restrict the Science Used in Policymaking
EPA Seeks to Restrict the Science Used in Policymaking
Kerry Grens | Apr 23, 2018
Republican politicians have been trying to limit data to only those publicly available, but opponents say that would neglect private, yet important, information.
Investigation Questions Transparency for Failed TB Vax
Investigation Questions Transparency for Failed TB Vax
Jef Akst | Jan 11, 2018
The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials.
Scientists Continue to Use Outdated Methods
Scientists Continue to Use Outdated Methods
Catherine Offord | Jan 8, 2018
The use of underperforming computational tools is a major offender in science’s reproducibility crisis—and there’s growing momentum to avoid it.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Many Editors of US Medical Journals Receive Industry Funding
Many Editors of US Medical Journals Receive Industry Funding
Shawna Williams | Nov 8, 2017
The authors of two new studies on the payments suggest stricter guidelines are needed.
Elsevier Signs Up to Transparency Guidelines
Elsevier Signs Up to Transparency Guidelines
Catherine Offord | Sep 5, 2017
The publisher will ask its journal editors to adopt widely accepted standards on transparency and openness in scientific communication.
Stem Cell Trial Data Mostly Go Unpublished
Stem Cell Trial Data Mostly Go Unpublished
Anna Azvolinsky | May 5, 2017
Less than half of completed stem cell studies in humans are published in peer-reviewed journals, according to an analysis of regenerative medicine trials. 
Notable Science Quotes
Notable Science Quotes
The Scientist Staff | Mar 1, 2017
Music, the future of American science, and more